☰

Andrew V. Albright, Ph.D. - Publications

Affiliations: 
2000 University of Pennsylvania, Philadelphia, PA, United States 
Area:
Microbiology Biology, Neuroscience Biology, Pathology
Tree Info Similar researchers PubMed Report error

18/30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Ryzhova EV, Vos RM, Albright AV, Harrist AV, Harvey T, González-Scarano F. Annexin 2: a novel human immunodeficiency virus type 1 Gag binding protein involved in replication in monocyte-derived macrophages. Journal of Virology. 80: 2694-704. PMID 16501079 DOI: 10.1128/Jvi.80.6.2694-2704.2006  0.719
2004 Albright AV, González-Scarano F. Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression. Journal of Neuroimmunology. 157: 27-38. PMID 15579277 DOI: 10.1016/J.Jneuroim.2004.09.007  0.59
2004 Albright AV, Vos RM, González-Scarano F. Low-level HIV replication in mixed glial cultures is associated with alterations in the processing of p55(Gag). Virology. 325: 328-39. PMID 15246272 DOI: 10.1016/J.Virol.2004.04.028  0.759
2003 Albright AV, Soldan SS, González-Scarano F. Pathogenesis of human immunodeficiency virus-induced neurological disease. Journal of Neurovirology. 9: 222-7. PMID 12707852 DOI: 10.1080/13550280390194073  0.768
2001 Albright AV, Martín J, O'Connor M, González-Scarano F. Interactions between HIV-1 gp120, chemokines, and cultured adult microglial cells. Journal of Neurovirology. 7: 196-207. PMID 11517394 DOI: 10.1080/13550280152403245  0.71
2001 Goldberg SH, van der Meer P, Hesselgesser J, Jaffer S, Kolson DL, Albright AV, González-Scarano F, Lavi E. CXCR3 expression in human central nervous system diseases. Neuropathology and Applied Neurobiology. 27: 127-38. PMID 11437993 DOI: 10.1046/J.1365-2990.2001.00312.X  0.626
2000 Albright AV, Erickson-Viitanen S, O'Connor M, Frank I, Rayner MM, González-Scarano F. Efavirenz is a potent nonnucleoside reverse transcriptase inhibitor of HIV type 1 replication in microglia in vitro. Aids Research and Human Retroviruses. 16: 1527-37. PMID 11054266 DOI: 10.1089/088922200750006056  0.737
2000 Albright AV, Shieh JT, O'Connor MJ, González-Scarano F. Characterization of cultured microglia that can be infected by HIV-1. Journal of Neurovirology. 6: S53-60. PMID 10871766  0.567
1999 Goldberg SH, Albright AV, Lisak RP, González-Scarano F. Polymerase chain reaction analysis of human herpesvirus-6 sequences in the sera and cerebrospinal fluid of patients with multiple sclerosis. Journal of Neurovirology. 5: 134-9. PMID 10321977 DOI: 10.3109/13550289909021995  0.529
1999 Albright AV, Frank I, González-Scarano F. Interleukin-2 treatment of microglia has no effect on in vitro HIV infection. Aids (London, England). 13: 527-8. PMID 10197386 DOI: 10.1097/00002030-199903110-00016  0.725
1999 Albright AV, Shieh JT, Itoh T, Lee B, Pleasure D, O'Connor MJ, Doms RW, González-Scarano F. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. Journal of Virology. 73: 205-13. PMID 9847323 DOI: 10.1128/Jvi.73.1.205-213.1999  0.762
1999 Goldberg SH, Hesselgesser J, Ulrich AM, Jaffer S, Kolson DL, Albright AV, Gonzalez-Scarano F, Lavi E. Immunohistochemical Analysis of CXCR3 Expression in Human Central Nervous System Diseases Journal of Neuropathology and Experimental Neurology. 58: 544. DOI: 10.1097/00005072-199905000-00153  0.518
1998 Albright AV, Lavi E, Black JB, Goldberg S, O'Connor MJ, González-Scarano F. The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia. Journal of Neurovirology. 4: 486-94. PMID 9839646 DOI: 10.3109/13550289809113493  0.67
1998 Fouchier RA, Meyer BE, Simon JH, Fischer U, Albright AV, González-Scarano F, Malim MH. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. Journal of Virology. 72: 6004-13. PMID 9621063 DOI: 10.1128/Jvi.72.7.6004-6013.1998  0.647
1998 Shieh JT, Albright AV, Sharron M, Gartner S, Strizki J, Doms RW, González-Scarano F. Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. Journal of Virology. 72: 4243-9. PMID 9557714 DOI: 10.1128/Jvi.72.5.4243-4249.1998  0.769
1996 Strizki JM, Albright AV, Sheng H, O'Connor M, Perrin L, González-Scarano F. Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism. Journal of Virology. 70: 7654-62. PMID 8892885 DOI: 10.1128/Jvi.70.11.7654-7662.1996  0.755
1996 Albright AV, Strizki J, Harouse JM, Lavi E, O'Connor M, González-Scarano F. HIV-1 infection of cultured human adult oligodendrocytes. Virology. 217: 211-9. PMID 8599205 DOI: 10.1006/Viro.1996.0108  0.766
1996 Albright AV, Lavi E, O'Connor M, González-Scarano F. HIV-1 infection of a CD4-negative primary cell type: The oligodendrocyte Perspectives in Drug Discovery and Design. 5: 43-50. DOI: 10.1007/Bf02174000  0.751
Low-probability matches (unlikely to be authored by this person)
2017 Ayers M, Lunceford J, Nebozhyn M, Murphy E, Loboda A, Kaufman DR, Albright A, Cheng JD, Kang SP, Shankaran V, Piha-Paul SA, Yearley J, Seiwert TY, Ribas A, McClanahan TK. IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. The Journal of Clinical Investigation. PMID 28650338 DOI: 10.1172/Jci91190  0.106
2021 Zhao H, Nickle DC, Zeng Z, Law PYT, Wilcox MH, Chen L, Peng Y, Meng J, Deng Z, Albright A, Zhong H, Xu X, Zhu S, Shen J, Blanchard RL, et al. Global Landscape of Clostridioides Difficile Phylogeography, Antibiotic Susceptibility, and Toxin Polymorphisms by Post-Hoc Whole-Genome Sequencing from the MODIFY I/II Studies. Infectious Diseases and Therapy. PMID 33751421 DOI: 10.1007/s40121-021-00426-6  0.098
2016 Arreaza G, Qiu P, Pang L, Albright A, Hong LZ, Marton MJ, Levitan D. Pre-Analytical Considerations for Successful Next-Generation Sequencing (NGS): Challenges and Opportunities for Formalin-Fixed and Paraffin-Embedded Tumor Tissue (FFPE) Samples. International Journal of Molecular Sciences. 17. PMID 27657050 DOI: 10.3390/ijms17091579  0.084
2022 Haddad RI, Seiwert TY, Chow LQM, Gupta S, Weiss J, Gluck I, Eder JP, Burtness B, Tahara M, Keam B, Kang H, Muro K, Albright A, Mogg R, Ayers M, et al. Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma. Journal For Immunotherapy of Cancer. 10. PMID 35217573 DOI: 10.1136/jitc-2021-003026  0.08
2018 Cristescu R, Mogg R, Ayers M, Albright A, Murphy E, Yearley J, Sher X, Liu XQ, Lu H, Nebozhyn M, Zhang C, Lunceford JK, Joe A, Cheng J, Webber AL, et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science (New York, N.Y.). 362. PMID 30309915 DOI: 10.1126/Science.Aar3593  0.078
2019 Merchlinsky M, Albright A, Olson V, Schiltz H, Merkeley T, Hughes C, Petersen B, Challberg M. The development and approval of tecoviromat (TPOXX), the first antiviral against smallpox. Antiviral Research. PMID 31181284 DOI: 10.1016/j.antiviral.2019.06.005  0.072
2021 Cristescu R, Nebozhyn M, Zhang C, Albright A, Kobie J, Huang L, Zhao Q, Wang A, Ma H, Cao ZA, Morrissey M, Ribas A, Grivas P, Cescon DW, McClanahan TK, et al. Transcriptomic Determinants of Response to Pembrolizumab Monotherapy Across Solid Tumor Types. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34965943 DOI: 10.1158/1078-0432.CCR-21-3329  0.062
2022 Cristescu R, Liu XQ, Arreaza G, Chen C, Albright A, Qiu P, Marton MJ. Concordance between single-nucleotide polymorphism-based genomic instability assays and a next-generation sequencing-based homologous recombination deficiency test. Bmc Cancer. 22: 1310. PMID 36517748 DOI: 10.1186/s12885-022-10197-z  0.037
2022 Cristescu R, Aurora-Garg D, Albright A, Xu L, Liu XQ, Loboda A, Lang L, Jin F, Rubin EH, Snyder A, Lunceford J. Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors. Journal For Immunotherapy of Cancer. 10. PMID 35101941 DOI: 10.1136/jitc-2021-003091  0.028
2022 Pfister DG, Haddad RI, Worden FP, Weiss J, Mehra R, Chow LQM, Liu SV, Kang H, Saba NF, Wirth LJ, Sukari A, Massarelli E, Ayers M, Albright A, Webber AL, et al. Biomarkers predictive of response to pembrolizumab in head and neck cancer. Cancer Medicine. PMID 36479637 DOI: 10.1002/cam4.5434  0.028
1999 Albright AV. Vulnerability to depression: youth at risk. The Nursing Clinics of North America. 34: 393-407. PMID 10318731  0.01
1984 Brady MA, Nelms BC, Albright AV, Murphy CM. Childhood depression: development of a screening tool. Pediatric Nursing. 10: 222-5, 227. PMID 6563513  0.01
Hide low-probability matches.